Clinical Trials Browser

OTHER × Keratosis, Actinic × Celecoxib × Clear all

NCT03643744 2024-12-19

Photodynamic Therapy-Induced Immune Modulation: Part III

Phase 1 Terminated

12 enrolled 9 charts

Keratosis, Actinic

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic